2(top 5%)
papers
117(top 5%)
citations
2(top 5%)
h-index
2(top 5%)
g-index
2
all documents
124
doc citations
59
citing journals
2
times ranked
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma | Allergy: European Journal of Allergy and Clinical Immunology | 2018 | 121 |
2 | 349TiP EPIK-B3: A phase III, randomised, double-blind (DB), placebo (PBO)-controlled study of alpelisib (ALP) + nab-paclitaxel (nab-PTX) in advanced triple-negative breast cancer (TNBC) with either PIK3CA mutation or phosphatase and tensin homolog (PTEN) loss without PIK3CA mutation | Annals of Oncology | 2020 | 3 |